Tesamorelin / Ipamorelin
GH Axis & Lipid Metabolism Research
$40.00
Out of stock
Product Description
Tesamorelin (10mg) and Ipamorelin (3mg) are commonly paired in research settings to explore optimized stimulation of endogenous growth hormone (GH) release through complementary mechanisms.
Tesamorelin, a GHRH analog, promotes GH production at the pituitary level, while Ipamorelin, a selective growth hormone secretagogue, enhances GH release via ghrelin receptor activation. Together, this combination is widely utilized to study controlled, pulsatile GH secretion and its downstream effects.
Key Research Applications
Growth Hormone & IGF-1 Modulation
Investigating natural GH pulse amplification and downstream signaling pathwaysBody Composition Studies
Focus on visceral fat dynamics and metabolic regulationRecovery & Cellular Repair Models
Exploring protein synthesis, tissue regeneration, and recovery signalingMetabolic Function Research
Evaluating glucose metabolism and insulin sensitivity pathways
Why This Combination
Dual-pathway GH stimulation (GHRH + GHS)
Supports more natural GH release patterns
Minimal impact on cortisol and prolactin (Ipamorelin)
Widely used in advanced peptide research models
Product Details
Tesamorelin: 10mg
Ipamorelin: 3mg
Form: Lyophilized powder
Purity: High-purity research grade
Testing: COA and lab verification available per batch
Important Notice
For research purposes only. Not for human or animal use & not FDA-approved.
By purchasing, you confirm you are 21 years of age or older and a qualified researcher.
Tesamorelin and Ipamorelin are frequently paired in research settings due to their complementary mechanisms in stimulating endogenous growth hormone (GH) release.
Tesamorelin is a growth hormone-releasing hormone (GHRH) analog that promotes the natural production of GH through pituitary stimulation.
Ipamorelin is a selective growth hormone secretagogue (GHS) that mimics ghrelin and triggers GH release without significantly impacting cortisol or prolactin levels.
When combined, researchers often select this pairing to:
Support pulsatile GH release (more natural secretion pattern)
Minimize unwanted hormonal side effects compared to older secretagogues
Evaluate synergistic effects on metabolic and recovery-related pathways
Provide a more targeted and controlled GH response
Researchers commonly explore Tesamorelin / Ipamorelin in the following areas:
Body Composition & Fat Metabolism
Investigation into visceral adipose tissue reduction
Effects on lipid metabolism and fat distribution
Growth Hormone Dynamics
Pulsatile GH secretion patterns
IGF-1 level modulation and downstream signaling
Muscle & Recovery Pathways
Protein synthesis and lean mass preservation
Cellular repair and recovery mechanisms
Metabolic Health
Glucose metabolism and insulin sensitivity
Potential implications in metabolic syndrome models
Aging & Longevity Research
GH/IGF-1 axis in age-related decline
Tissue regeneration and repair signaling pathways
1. Tesamorelin – Visceral Fat Reduction Study (Phase 3 Trials)
Falutz et al., 2010
Demonstrated reduction in visceral adipose tissue via GH stimulation
👉 Read study on NCBI
2. Tesamorelin – Effects on Body Composition & Muscle
Secondary analysis of clinical trials on fat and muscle outcomes
👉 View full article (PubMed Central)
3. Ipamorelin – Selective Growth Hormone Secretagogue
Raun et al., 1998
Found Ipamorelin to be a potent and selective GH-releasing peptide
👉 View PubMed abstract
4. Growth Hormone Secretagogues – Mechanisms & Effects
Overview of GH peptides and their role in body composition and metabolism
👉 Read full review (PMC)
5. GHRH Effects on Cognition, IGF-1, and Body Fat
Baker et al., 2012
Showed increased IGF-1 and reduced body fat with GHRH stimulation
👉 View PubMed study
